STORAGE Lyophilized -20 C 24 months Reconstituted 2-8 C, 28 days PEER-REVIEWED EVIDENCE Heffernan M, et al
Medication name: * Tri Bedoyecta Comparable patent medicine: Bedoyecta * Tri Active ingredient: hydroxocobalamin (vitamin B12), Thiamine (Vit B1), Pyridoxine (Vit B6) Presentation: Solution for Injection Concentration: 10.000 mg/100 mg/50 mg Extended-release tablets: No Lab: Grossman, S
Oral orfoglipron, as opposed to peptide-based oral semaglutide, can be taken without regard to food timing
A summary of current supportive management is provided in Table 3 and a treatment flowchart is provided in Figure 3
According to the NHS, treating deficiency early prevents long-term complications
Results appear gradually and can continue to improve in the months following treatment due to increased collagen production